Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2022)
Attributed to:
Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)00163-5
PubMed Identifier: 35151397
Publication URI: http://europepmc.org/abstract/MED/35151397
Type: Journal Article/Review
Volume: 399
Parent Publication: Lancet (London, England)
Issue: 10325
ISSN: 0140-6736